Ngā hua rapu - Pinter Abraham

  • E whakaatu ana i te 1 - 8 hua o te 8
Whakamahine hua
Rārangi   Mātiti  
  1. 1

    The Hypervariable Domain of the Murine Leukemia Virus Surface Protein Tolerates Large Insertions and Deletions, Enabling Development of a Retroviral Particle Display System mā Kayman, Samuel C., Park, Han, Saxon, Maya, Pinter, Abraham

    I whakaputaina i J Virol (1999)
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2

    Distinct Mechanisms of Neutralization by Monoclonal Antibodies Specific for Sites in the N-Terminal or C-Terminal Domain of Murine Leukemia Virus SU mā Burkhart, Michael Dominic, Kayman, Samuel C., He, Yuxian, Pinter, Abraham

    I whakaputaina i J Virol (2003)
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3

    Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing mā Wang Shixia, Krachmarov Chavdar, Sharpe-Cohen Sandra, Zolla-Pazner Susan, Pinter Abraham, Lu Shan

    I whakaputaina 2006-12-01
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4

    The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Inf... mā Pinter, Abraham, Honnen, William J., He, Yuxian, Gorny, Miroslaw K., Zolla-Pazner, Susan, Kayman, Samuel C.

    I whakaputaina i J Virol (2004)
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5

    Antibodies That Are Cross-Reactive for Human Immunodeficiency Virus Type 1 Clade A and Clade B V3 Domains Are Common in Patient Sera from Cameroon, but Their Neutralization Activit... mā Krachmarov, Chavdar, Pinter, Abraham, Honnen, William J., Gorny, Miroslaw K., Nyambi, Phillipe N., Zolla-Pazner, Susan, Kayman, Samuel C.

    I whakaputaina i J Virol (2005)
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6

    Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades mā Gorny, Miroslaw K., Williams, Constance, Volsky, Barbara, Revesz, Kathy, Cohen, Sandra, Polonis, Victoria R., Honnen, William J., Kayman, Samuel C., Krachmarov, Chavdar, Pinter, Abraham, Zolla-Pazner, Susan

    I whakaputaina i J Virol (2002)
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7

    HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection mā Basu Debby, Kraft Colleen S, Murphy Megan K, Campbell Patricia J, Yu Tianwei, Hraber Peter T, Irene Carmela, Pinter Abraham, Chomba Elwyn, Mulenga Joseph, Kilembe William, Allen Susan A, Derdeyn Cynthia A, Hunter Eric

    I whakaputaina 2012-09-01
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8

    The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope mā Gorny, Miroslaw K., Revesz, Kathy, Williams, Constance, Volsky, Barbara, Louder, Mark K., Anyangwe, Christopher A., Krachmarov, Chavdar, Kayman, Samuel C., Pinter, Abraham, Nadas, Arthur, Nyambi, Phillipe N., Mascola, John R., Zolla-Pazner, Susan

    I whakaputaina i J Virol (2004)
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: